You are here: Industry Insights > Golden Meditech

News List

Golden Meditech's Associate, Cellenkos, Focuses on the Development of Cell-theray for Treatment of COVID-19 Mediated Acute Respiratory Distress Syndrome (CoV-ARDS) prnasia
March 18, 2020
Cellenkos will leverage its clinical experience with CK0802 for other inflammatory disorders, including amyotrophic lateral sclerosisand and fast-track development of CK0802 to treat respiratory complications caused by COVID-19 infection.
Golden Meditech, HKBU team up to conduct cell therapy research biospectrumasia
April 21, 2019
The Department of Biology of HKBU has been committed to conducting research on cell therapy for treating neurodegenerative diseases.
Golden Meditech's Largest Shareholder Acquired Additional 9,068,000 Shares prnasia
March 15, 2018
Golden Meditech Holdings Limited announce that the Company's largest shareholder Mr. Kam Yuen, Chairman and Chief Executive Officer of the Group, has further increased his shareholding in Golden Meditech by acquiring a total of 9,068,000 shares through B